Evoke Pharma Reports Third Quarter 2017 Results and Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Evoke Pharma (EVOK) Misses Q3 EPS by 14c
November 14, 2017 4:06 PM ESTEvoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.34), $0.14 worse than the analyst estimate of ($0.20).
As of September 30, 2017, our cash and cash equivalents were approximately $10.4 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
... More